ZAP70 and hyperinsulinemic hypoglycemia, familial, 4: The heterogeneity in ZAP70 mutations, clinical manifestations, and frequent need for treatment with a hematopoietic stem cell transplant (HSCT), can make it difficult to achieve a comprehensive immunologic and molecular view of ZAP70 deficiency in humans.